Research is an integral part of the UC Davis Spine Center. Our team contributes to advances in spine care through pioneering investigations of new treatments and technologies. We are currently enrolling participants in studies and clinical trials focused on:

Spinal cord injury

  • Acute intervention with spinal scaffold
  • Acute intervention with investigational drug

Degenerative disk disease

  • Stem cell therapy

Spine trauma

  • Fractures of the odontoid bone

Current Neuro Spine Studies and Research

Lumbar Disc Herniation Study

Lead investigator: Kee D. Kim, M.D.
Project description: The primary goal of this clinical trial is to test the effectiveness of a single-dose intervertebral disc injection. The investigational drug will be tested in patients with lumbar disc herniation (LDH). The study drug works by reducing the pressure in the disc thereby possibly reducing nerve root compression. Participants will be randomized to receive a single intrasdiscal injection of the study drug, or a sham injection (control). identifier: NCT03607838

The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal ScaffoldTM for Safety and Neurologic Recovery in Subjects With Complete Thoracic AIS A Spinal Cord Injury

Sponsor: InVivo Therapeutics
Lead investigator: Kee D. Kim, M.D.
Project description: Multi-center study investigating an implantable scaffold at the time of spinal stabilization. The scaffold is designed to provide structural support to injured spinal tissue and a supportive matrix for endogenous healing/repair processes following implantation within a spinal cord contusion, thereby preserving spinal tissue and increasing the chances for functional recovery. identifier: NCT02138110 

Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

Sponsor: Vertex Pharmaceuticals
Lead investigator: Kee D. Kim, M.D.
Project description: Multi-center study looking at the efficacy and safety of VX-210 in subjects with acute traumatic cervical spinal cord Injury. Secondary objectives include the specific evaluation of the effects of VX-210 on neurological recovery and daily function after spinal cord injury. VX-210 is designed to inhibit a protein known as rho that blocks neural regeneration after injury. identifier: NCT0266984 

Safety and Efficacy Study of Rexlemestrocel-L in Subjects With Chronic Discogenic Lumbar Back Pain (Mesoblast, Ltd.)

Sponsor: Mesoblast Ltd.
Lead investigator: Kee D. Kim, M.D.
Project description: Multicenter, randomized, double-blind, placebo-controlled Phase 3 study designed to evaluate the safety and efficacy of Mesoblast's rexlemestrocel-L alone or combined with hyaluronic acid in subjects with chronic discogenic lumbar back pain (> 6 months) associated with moderate degenerative disc disease. identifier: NCT0241273 

Odontoid Fracture Study Treated With Pulsed Electromagnetic Fields (PEMF)

Sponsor: Orthofix Inc.
Lead investigator: Kee D. Kim, M.D.
Project description: The purpose of this study is to see if PEMF treatment will improve odontoid fracture healing, compared with standard conservative care, in subjects 50 years of age diagnosed with type II odontoid fractures. identifier: NCT02281994


For more information on clinical research projects at the UC Davis Spine Center, please call 916-734-3660.